Our research expertise spans cancer genomics, DNA damage, RNA biology, and drug development. We are also expanding our focus on drug delivery, particularly through nanotechnology-based methods for delivering small RNA mimics and inhibitors.
Registration is now open!
News
- Int’l Journal of Molecular Sciences: The Role of the Tumor Microenvironment (TME) in Advancing Cancer Therapies: Immune System Interactions, Tumor-Infiltrating Lymphocytes (TILs), and the Role of Exosomes and Inflammasomes (Aune Lab)
- Progress in Neurobiology: Pathogenic Oligomeric Tau alters Neuronal RNA Processes through the Formation of Nuclear Heteromeric Amyloids with RNA-Binding Protein Musashi1 (Penalva)
- Texas Public Radio: Science & Medicine: Sabotaging the molecular engines of some pediatric cancers (Gupta)
- ELife: SERBP1 interacts with PARP1 and is present in PARylation-dependent protein complexes regulating splicing, cell division, and ribosome biogenesis (Libich, Penalva, et al)
- ELife: Structure of METTL3-METTL14 with an m6A nucleotide reveals insights into m6A conversion and sensing (Rao, Gupta, et al)
Events
Greehey CCRI Seminar Series: Kate Lawrenson, PhD (UTHSA, Department of Obstetrics & Gynecology)
Presentation title: “Ovarian” Cancer Prevention Through Understanding Tumor Precursors”
Greehey CCRI Seminar Series: Harmit Malik, PhD (Fred Hutch Cancer Center)
Presentation title: “Genetic Conflicts During Meiosis Shape the Rapid Evolution of Essential Chromatin Proteins.”
Greehey CCRI Seminar Series: Gang Huang (UTHSA, Department of Cell Systems and Anatomy)
Presentation title: TBD
Greehey CCRI Seminar Series: Andrew J Brenner, MD, PhD (UTHSA – Dept Cell Systems and Anatomy)
Presentation title: TBD